TV Ratings on April 25, 2011

April 25, Monday, Kantar Media National TV Ratings

Daytime:

Gising Pilipinas (0.6%) / Kape’t Pandasal (0.8%) vs. Born To Be Wild (Replay) (0.5%)
Umagang Kay Ganda (4.3%) vs. Unang Hirit (4.0%)
NBA 2011 Live (7.4%) vs. Doraemon (10.1%) / Jackie Chan Adventures (12.2%) / Ghost Fighter (12.6%) / Dragon Ball Z Kai (13.2%) / Star Box Dito Kasali Ka! (6.6%)
Showtime (12.1%) vs. Family Feud The Showdown Edition (6.6%) / Kitchen Superstar (10.3%)
Happy Yipee Yehey! (8.2%) vs. Eat… Bulaga! (15.7%)
Kapamilya Blockbusters ‘Home Along Da Riles 2′ (8.8%) vs. Alakdana (9.4%) / Nita Negrita (10.2%)
Frijolito (8.4%) vs. My Lover My Wife (11.9%)
My Princess (8.5%) vs. Temptation Of Wife (14.5%)

Primetime:

Mula Sa Puso (14.8%) vs. Magic Palayok (12.0%)
TV Patrol (22.2%) vs. 24 Oras (16.5%)
Mutya (26.2%) vs. Captain Barbell (16.7%)
Minsan Lang Kita Iibigin (28.6%) vs.Dwarfina (18.9%)
Mara Clara (30.2%) vs. I Heart You Pare (14.7%)
Imortal (21.9%) / Green Rose (13.7%) vs. The Baker King (15.6%)
SNN Showbiz News Ngayon (8.2%) vs. Saksi Liga Ng Katotohanan (5.6%)
Bandila (4.4%) / XXX (Exklusibong Explosibong Expose) (3.2%) vs. I-Witness The GMA Documentaries (2.3%)
M.U. Live (0.9%)

April 25, Monday, AGB Nielsen Mega Manila People’s Ratings

Daytime:

1. Eat Bulaga! (GMA-7) – 11.4%
2. Temptation of Wife (GMA-7) – 8.8%
3. My Lover My Wife (GMA-7) – 8%
4. Dragon Ball Z Kai (GMA-7) – 7.1%
5. Nita Negrita (GMA-7) – 6.4%
6. Kitchen Superstar (GMA-7) – 6.3%
7. Ghost Fighter (GMA-7) – 5.9%
8. Alakdana (GMA-7) – 5.8%
9. Face To Face (TV5) – 5.6%
10. Showtime (ABS-CBN) – 5.3%

Primetime:

1. Dwarfina (GMA-7) / Mara Clara (ABS-CBN) – 13.4%
2. The Baker King (GMA-7) – 13.2%
3. Minsan Lang Kita Iibigin (ABS-CBN) – 12%
4. Captain Barbell (GMA-7) – 11.3%
5. I ♥You Pare (GMA-7) – 10.9%
6. Imortal (ABS-CBN) – 10%
7. 24 Oras (GMA-7) – 9.6%
8. Mutya (ABS-CBN) – 9.3%
9. TV Patrol (ABS-CBN) / Primetime Super Sine: Jaws (TV5) – 9.1%
10. Magic Palayok (GMA-7) – 7.4%

Source: Kantar Media and AGB Nielsen Philippines

0 comments:

Post a Comment